SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

9.26
Delayed Data
As of May 29
 -0.21 / -2.22%
Today’s Change
4.68
Today|||52-Week Range
9.87
+5.71%
Year-to-Date

Today’s Trading

Previous close9.47
Today’s open9.47
Day’s range9.25 - 9.51
Volume290,231
Average volume (3 months)424,476
Market cap$459.3M
Dividend yield--
Data as of 3:59pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)+140.00%
Earnings growth (this year)-10.42%
Earnings growth (next 5 years)+14.70%
Revenue growth (last year)+6.09%
P/E ratio16.2
Price/Sales3.33
Price/Book3.05

Competitors

 Today’s
change
Today’s
% change
LBIOLion Biotechnologies...+0.70+6.67%
VSARVersartis Inc-0.25-1.58%
PETXAratana Therapeutics...-0.13-0.95%
TBPHTheravance Biopharma...-0.38-2.65%
Data as of 3:59pm ET, 05/29/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)$0.11
Annual revenue (last year)$134.8M
Annual profit (last year)$25.2M
Net profit margin18.70%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Friedhelm Blobel
Chief Financial Officer &
Senior Vice President
Wai-Shun Wilson Cheung
Corporate headquarters
Foster City, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers